Alvotech (ALVO)
5.24
+0.17
(+3.35%)
USD |
NASDAQ |
Dec 05, 09:50
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.633B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -55.91% |
| Valuation | |
| PE Ratio | 22.75 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.885 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -7.254 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg. |
| URL | http://www.alvotech.com |
| Investor Relations URL | https://investors.alvotech.com/ |
| HQ State/Province | Luxembourg |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Mar. 25, 2026 (est.) |
| Last Earnings Release | Nov. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg. |
| URL | http://www.alvotech.com |
| Investor Relations URL | https://investors.alvotech.com/ |
| HQ State/Province | Luxembourg |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Mar. 25, 2026 (est.) |
| Last Earnings Release | Nov. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |